Lexicon Pharmaceuticals
LXRX
#7546
Rank
A$0.42 B
Marketcap
$1.19
Share price
-4.42%
Change (1 day)
-28.03%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.02

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.04. In 2022 the company made an earnings per share (EPS) of -$0.94 an increase over its 2021 EPS that were of -$0.94.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.028.9%
2022-$0.94-0%
2021-$0.9410.91%
2020-$0.84-145.08%
2019$1.87-206.09%
2018-$1.77-5.74%
2017-$1.87-10.95%
2016-$2.102640%
2015-$0.07679-96.34%
2014-$2.10-2.53%
2013-$2.15-9.09%
2012-$2.36-37.14%
2011-$3.760%
2010-$3.76-39.66%
2009-$6.233.57%
2008-$6.02-8.2%
2007-$6.56-24.69%
2006-$8.7142.11%
2005-$6.13-22.97%
2004-$7.95-35.09%
2003-$12.25-0%
2002-$12.2562.86%
2001-$7.52-19.54%
2000-$9.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$8.66 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.37-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$15.73 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.20-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.56-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.33 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$40.86 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.41-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.15 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA